BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 7504401)

  • 1. Cytokine profile during high-dose rhG-CSF therapy in severe congenital neutropenia.
    Shitara T; Yugami S; Ijima H; Sotomatu M; Kuroume T
    Am J Hematol; 1994 Jan; 45(1):58-62. PubMed ID: 7504401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
    Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC
    Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cytokine levels and abnormal response of myeloid progenitor cells to granulocyte colony-stimulating factor in a case of severe congenital neutropenia. In vitro effects of stem cell factor.
    Shitara T; Ijima H; Yugami S; Sotomatu M; Kuroume T
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):167-72. PubMed ID: 7513137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of G-CSF, IL-3, IL-6 and GM-CSF after a single intraperitoneal dose of rhG-CSF in lethally irradiated B6D2F1 mice.
    Kádár E; Sureda A; Mangues MA; Inglés-Esteve J; Valls A; García J
    Acta Haematol; 1997; 98(3):119-24. PubMed ID: 9352740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia.
    Ishikawa K; Tanaka H; Matsuoka T; Shimazu T; Yoshioka T; Sugimoto H
    J Trauma; 1998 Jun; 44(6):1047-54; discussion 1054-5. PubMed ID: 9637161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant human granulocyte-colony stimulation factor (rhG-CSF) on immune system in pediatric patients with aplastic anemia.
    Hibi S; Yoshihara T; Nakajima F; Misu H; Mabuchi O; Imashuku S
    Pediatr Hematol Oncol; 1994; 11(3):319-23. PubMed ID: 7520260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia.
    Bernini JC; Wooley R; Buchanan GR
    J Pediatr; 1996 Oct; 129(4):551-8. PubMed ID: 8859262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
    Hellmich B; Schnabel A; Gross WL
    Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer.
    Setti M; Bignardi D; Ballestrero A; Ferrando F; Musselli C; Blanchi S; Basso M; Bosco O; Balleari E; Patrone F; Indiveri F
    Cancer Immunol Immunother; 1999 Sep; 48(6):287-96. PubMed ID: 10473803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor.
    MacVittie TJ; Farese AM; Herodin F; Grab LB; Baum CM; McKearn JP
    Blood; 1996 May; 87(10):4129-35. PubMed ID: 8639770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
    Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
    Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.
    Welte K; Zeidler C; Reiter A; Müller W; Odenwald E; Souza L; Riehm H
    Blood; 1990 Mar; 75(5):1056-63. PubMed ID: 1689595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum TNF-alpha, gamma-INF, G-CSF and GM-CSF levels in neutropenic children with acute leukemia treated with short-course, high-dose methylprednisolone.
    Tuncer AM; Hiçsönmez G; Gümrük F; Sayli T; Güler E; Cetin M; Okur H
    Leuk Res; 1996 Mar; 20(3):265-9. PubMed ID: 8637222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of recombinant human granulocyte colony-stimulating factor in serum are inversely correlated with circulating neutrophil counts.
    Takatani H; Soda H; Fukuda M; Watanabe M; Kinoshita A; Nakamura T; Oka M
    Antimicrob Agents Chemother; 1996 Apr; 40(4):988-91. PubMed ID: 8849265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.
    Huang W; Liu J; Zeng Y; Wu F; Li N; Chen K; Hong Y; Wang L; Zhen H; Lin L
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):607-613. PubMed ID: 30043207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluctuations in serum cytokine levels in the patient with cyclic neutropenia.
    Yujiri T; Shinohara K; Kurimoto F
    Am J Hematol; 1992 Feb; 39(2):144-5. PubMed ID: 1372466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
    Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
    Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 alpha and soluble interleukin-2 receptor during small cell lung cancer chemotherapy: comparison of high chemotherapy dose with rhGM-CSF and standard chemotherapy dose without rhGM-CSF.
    Gautier V; Pujol JL; Michel FB
    Lung Cancer; 1995 Oct; 13(2):145-53. PubMed ID: 8581394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autografts.
    Kawano Y; Takaue Y; Saito S; Sato J; Shimizu T; Suzue T; Hirao A; Okamoto Y; Abe T; Watanabe T
    Blood; 1993 Feb; 81(3):856-60. PubMed ID: 7679001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.